His research focuses on generating pluripotent stem cell models (PSC) of Alzheimer’s disease. This includes generation of patient-specific induced pluripotent stem cell (iPSC) lines and by using genome editing technologies to create allelic libraries of isogenic disease and control PSC lines. These human-specific tools may help elucidate pathological mechanisms of Alzheimer’s disease and provide a better platform for therapeutic development.